""	"submission_name"	"submission_date"	"template_name"	"tissue_type"	"response_component_original"	"response_component"	"cell_ontology_id"	"proterm_and_extra"	"pro_ontology_id"	"fully_qualified_response_component"	"response_behavior_type"	"response_behavior"	"subgroup"	"time_point"	"time_point_units"	"baseline_time"	"target_pathogen"	"vaccine_year"	"exposure_material_text"	"exposure_material"	"additional_exposure_material"	"comparison"	"cohort"	"publication_reference"	"publication_year"	"signature_source"	"signature_source_url"	"comments"	"publication_reference_url"	"age_group"	"age_min"	"age_max"	"age_units"	"subm_obs_id"	"uniq_obs_id"	"response_comp_cnt"	"signature_file"
"subject"	""	""	""	"cell_subset"	""	"cell_subset"	""	""	""	""	""	""	""	""	""	""	"pathogen"	""	""	"vaccine"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"evidence"	""	""	""	""	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"file"
"role"	""	""	""	"tissue"	"observed"	"cell_biomarker"	"observed"	"observed"	"observed"	"observed"	"background"	"measured"	"background"	"observed"	"observed"	"background"	"pathogen"	"background"	"background"	"vaccine"	"background"	"background"	"observed"	"background"	"background"	"background"	"background"	"background"	"reference"	"observed"	"observed"	"observed"	"observed"	"background"	"background"	"observed"	"observed"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	""	""	""	"tissue type"	"response component (original)"	"response component (cell subset)"	"cell ontology ID"	"cell type PRO and extra terms"	"protein ontology ID"	"all response components in signature"	"response behavior type"	"response behavior"	"subgroup"	"time point"	"time point units"	"baseline time"	"target pathogen"	"vaccine year"	"exposure material (name)"	"exposure material (VO)"	"additional exposure material"	"comparison"	"cohort"	"publication reference (PMID)"	"publication year"	"signature source figure, table or text section"	"signature source url"	"comments and additional details"	"Osman et al. (2017) A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH. PLoS Negl Trop Dis PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=28498840' target='_blank'>28498840</a>"	"cohort"	"min. age"	"max. age"	"age units"	"ID of observation within its submission"	"Uniq ID of observation within submission type"	"response component count"	"signature response component (cell types) file"
""	"hipc_ctf_28498840_2"	"2017.05"	"hipc_ctf_28498840_2"	"blood"	"monocyte"	"monocyte"	"CL_0000576"	""	""	"monocyte"	"cell type frequency"	"up"	"high-dose"	"24"	"hours"	"time of vaccination (first dose)"	"leishmania donovani"	""	"ChAd63-KH"	"VO_0003961"	""	"24hr-0hr"	"Adullts (18-50)"	"28498840"	"2017"	""	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443534/"	"adults"	"18"	"50"	"years"	"2"	"136"	"2"	"hipc_ctf_sig_28498840_2.txt"
""	"hipc_ctf_28498840_2"	"2017.05"	"hipc_ctf_28498840_2"	"blood"	"activated DC"	"dendritic cell"	"CL_0000451"	"& activated"	""	"dendritic cell & activated"	"cell type frequency"	"up"	"high-dose"	"24"	"hours"	"time of vaccination (first dose)"	"leishmania donovani"	""	"ChAd63-KH"	"VO_0003961"	""	"24hr-0hr"	"Adullts (18-50)"	"28498840"	"2017"	""	""	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443534/"	"adults"	"18"	"50"	"years"	"2"	"136"	"2"	"hipc_ctf_sig_28498840_2.txt"
